Senscure Biotechnology Overview
- Year Founded
-
2011
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Investors
-
4
Senscure Biotechnology General Information
Description
Provider of surgical devices designed to innovate and improve minimally invasive surgery technology. The company's devices focuses on tumor treatment and offers series of products such as laparoscopic single port multi-channel access platform, pulmonary nodule localization needle, tumor cryoablation system and anti-gastroesophageal reflux system, enabling users to get complete medical equipment for surgeries.
Contact Information
Website
www.senscure.netCorporate Office
- Building 3, Block B, Number 777, Binhai 4th Road
- Hangzhou Bay New District
- Ningbo, Zhejiang 315336
- China
Corporate Office
- Building 3, Block B, Number 777, Binhai 4th Road
- Hangzhou Bay New District
- Ningbo, Zhejiang 315336
- China
Senscure Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC | 24-May-2019 | Completed | Generating Revenue | |||
| 1. Later Stage VC (Series A) | 27-Mar-2018 | Completed | Generating Revenue |
Senscure Biotechnology Patents
Senscure Biotechnology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026124668-A1 | Liquid nitrogen cryoablation system and control method therefor | Pending | 12-Dec-2024 | ||
| WO-2026082175-A1 | Cryoablation system | Pending | 18-Oct-2024 | ||
| WO-2026056904-A1 | Spray cryoablation catheter, sealing device, and catheter | Pending | 10-Sep-2024 | ||
| WO-2025153115-A1 | Balloon catheter | Pending | 19-Jan-2024 | ||
| WO-2024149191-A1 | Ablation device for airway tissue, system and control method | Inactive | 09-Jan-2023 |
Senscure Biotechnology Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Proxima Capital | Venture Capital | Minority | ||
| Shengshan Asset Management | Venture Capital | Minority | ||
| Furong Capital | Growth/Expansion | Minority | ||
| YuanBio Venture Capital | Venture Capital | Minority |
Senscure Biotechnology FAQs
-
When was Senscure Biotechnology founded?
Senscure Biotechnology was founded in 2011.
-
Where is Senscure Biotechnology headquartered?
Senscure Biotechnology is headquartered in Ningbo, China.
-
What industry is Senscure Biotechnology in?
Senscure Biotechnology’s primary industry is Surgical Devices.
-
Is Senscure Biotechnology a private or public company?
Senscure Biotechnology is a Private company.
-
What is Senscure Biotechnology’s current revenue?
The current revenue for Senscure Biotechnology is .
-
How much funding has Senscure Biotechnology raised over time?
Senscure Biotechnology has raised $9.5M.
-
Who are Senscure Biotechnology’s investors?
Proxima Capital, Shengshan Asset Management, Furong Capital, and YuanBio Venture Capital have invested in Senscure Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process